Notes And Other Explanatory Information [Abstract]

Pharming Group N.V. - Filing #5829944

Concept 2024-01-01 to
2024-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]
Disclosure of allowance for credit losses [text block]
Disclosure of auditors' remuneration [text block]
Disclosure of authorisation of financial statements [text block]
Disclosure of basis of preparation of financial statements [text block]
Disclosure of borrowings [text block]
Disclosure of commitments [text block]
Disclosure of cost of sales [text block]
Disclosure of credit risk [text block]
Disclosure of deferred taxes [text block]
Disclosure of depreciation and amortisation expense [text block]
Disclosure of earnings per share [text block]
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of employee benefits [text block]
Disclosure of entity's operating segments [text block]
Disclosure of events after reporting period [text block]
Disclosure of expenses [text block]
Disclosure of fair value measurement [text block]
Disclosure of finance income (cost) [text block]
Disclosure of financial instruments [text block]
Disclosure of financial risk management [text block]
Disclosure of first-time adoption [text block]
Disclosure of general and administrative expense [text block]
Disclosure of general information about financial statements [text block]
Disclosure of going concern [text block]
Disclosure of government grants [text block]
Disclosure of impairment of assets [text block]
Disclosure of income tax [text block]
Disclosure of information about employees [text block]
Disclosure of information about key management personnel [text block]
Disclosure of interests in other entities [text block]
Disclosure of inventories [text block]
Disclosure of investments accounted for using equity method [text block]
Disclosure of investments other than investments accounted for using equity method [text block]
Disclosure of issued capital [text block]
Disclosure of leases [text block]
Disclosure of liquidity risk [text block]
Disclosure of material accounting policy information [text block]
Disclosure of other current liabilities [text block]
Disclosure of other operating income [text block]
Disclosure of property, plant and equipment [text block]
Disclosure of related party [text block]
Disclosure of research and development expense [text block]
Disclosure of reserves within equity [text block]
Disclosure of restricted cash and cash equivalents [text block]
Disclosure of revenue [text block]
Disclosure of share capital, reserves and other equity interest [text block]
Disclosure of share-based payment arrangements [text block]
Disclosure of subsidiaries [text block]
Disclosure of trade and other receivables [text block]

Talk to a Data Expert

Have a question? We'll get back to you promptly.